Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease

Circulation

Volumn 107, Issue 7, 2003, Pages 996-1002

  Hoffman, Timothy M ^a   Wemovsky, Gil ^a   Atz, Andrew M ^b   Kulik, Thomas J ^c   Nelson, David P ^d   Chang, Anthony C ^e   Bailey, James M ^f   Akbary, Akbar ^g   Kocsis, John F ^g   Kaczmarek, Raymond ^h   Spray, Thomas L ^a   Wessel, David L ⁱ  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^e TEXAS CHILDREN S HOSPITAL   (United States)

^f EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g Sanofi Synthelabo Inc   (United Kingdom)

^h Global Clinical Practice and Strategic Development Services   (United States)

ⁱ BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Cardiac output; Congenital; Heart defects; Mortality; Pediatrics

Indexed keywords

INOTROPIC AGENT; MILRINONE;

ARTICLE; CLINICAL TRIAL; CONGENITAL HEART DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INFUSION; DRUG SAFETY; FEMALE; FOLLOW UP; FORWARD HEART FAILURE; HEART SURGERY; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HIGH RISK POPULATION; HUMAN; HYPOTENSION; INFANT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; POSTOPERATIVE COMPLICATION; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; RISK MANAGEMENT; THROMBOCYTOPENIA; TREATMENT OUTCOME;

BLOOD PRESSURE; CARDIAC OUTPUT, LOW; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; ENDPOINT DETERMINATION; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; INFANT; INFANT, NEWBORN; LACTIC ACID; MALE; MILRINONE; OXYGEN; SYNDROME;

EID: 0037465355     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000051365.81920.28     Document Type: Article

References (15)

1. Parr GVS, Blackstone EH, Kirklin JW. Cardiac performance and mortality early after intracardiac surgery in infants and young children. Circulation. 1975;51:867-874.
2. Wernovsky G, Wypij D, Jonas RA, et al. Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants: a comparison of low-flow cardiopulmonary bypass and circulatory arrest. Circulation. 1995;92:2226-2235.
3. Pesonen EJ, Peltola KI, Korpela RE, et al. Delayed impairment of cerebral oxygenation after deep hypothermic circulatory arrest in children. Ann Thorac Surg. 1999;67:1765-1770.
4. du Plessis AJ, Jonas RA, Wypij D, et al. Perioperative effects of alpha-star versus pH-stat strategies for deep hypothermic cardiopulmonary bypass in infants. J Thorac Cardiovasc Surg. 1997;114:991-1000.
5. Nagashima M, Imai Y, Seo K, et al. Effect of hemofiltrated whole blood pump priming on hemodynamics and respiratory function after the arterial switch operation in neonates. Ann Thorac Surg. 2001;70:1901-1906.
6. Wright EM, Skoyles J, Sherry KM. Milrinone in the treatment of low output states following cardiac surgery. Eur J Anaesthesiol. 1992;9(suppl 5):21-26.
7. Ramamoorthy C, Anderson GD, Williams GD, et al. Pharmacokinetics and side effects of milrinone in infants and children after open heart surgery. Anesth Analg. 1998;86:283-289.
8. Chang AC, Atz AM, Wernovsky G. et al. Milrinone: systemic and pulmonary hemodynamic effects in neonates after cardiac surgery. Crit Care Med. 1995;23:1907-1914.
9. Bailey JM, Miller BE, Lu W, et al. The pharmacokinetics of milrinone in pediatric patients after cardiac surgery. Anesthesiology. 1999;90: 1012-1018.
10. Feneck RO. Intravenous milrinone following cardiac surgery, I: effects of bolus infusion followed by variable dose maintenance infusion. The European Milrinone Multicentre Trial Group. J Cardiothorac Vasc Anesth. 1992;6:554-562.
11. Lang P, Wessel DL, Wernovsky G, et al. Hemodynamic effects of amrinone in infants after cardiac surgery. In: Crupi G, Parenzan L, Anderson RH, eds. Perspectives in Pediatric Cardiology: Vol 2. Pediatric Cardiac Surgery, Part 2. Mount Kisco: Futura Publishing; 1989:292-295.
12. Kikura M, Sato S. The efficacy of preemptive Milrinone or Amrinone therapy in patients undergoing coronary artery bypass grafting. Anesth Analg. 2002;94:22-30.
13. Hoffman TM, Wemovsky G, Atz AM, et al. Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study. Am Heart J. 2002;143:15-21.
14. Kulik TJ, Moler FW, Palmisano JM, et al. Outcome-associated factors in pediatric patients treated with extracorporeal membrane oxygenator after cardiac surgery. Circulation. 1996;94:II-63-II-68.
15. Charpie JR, Kekeon MK, Goldberg CS, et al. Serial blood lactate measurements predict early outcome after neonatal repair or palliation for complex congenital heart disease. J Thorac Cardiovasc Surg. 2000;120: 73-80.